# Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

> **NCT00002565** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 61 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** CHOP regimen
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** idarubicin
- **DRUG:** ifosfamide
- **DRUG:** mesna
- **DRUG:** methylprednisolone
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednisone
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00002565
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-05-25
- **Primary completion:** 2007-02-05
- **Final completion:** 2007-02-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002565, "Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*